Review: taking Coumadin and Sertraline together


Summary

Drug interactions are reported among people who take Coumadin and Sertraline together. This review analyzes the effectiveness and drug interactions between Coumadin and Sertraline. It is created by eHealthMe based on reports of 4,309 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Coumadin and Sertraline >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Coumadin

Coumadin has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Coumadin 80,735 users)

Sertraline

Sertraline has active ingredients of sertraline hydrochloride. It is often used in depression. (latest outcomes from Sertraline 31,278 users)

On Aug, 22, 2016

4,309 people who take Coumadin, Sertraline are studied.


Number of reports submitted per year:

Coumadin and Sertraline drug interactions.

Drug effectiveness over time:

Coumadin:
  • < 1 month: 0.0% - (0 of 4 people)
  • 1 - 6 months: 62.0% - (5 of 8 people)
  • 6 - 12 months: 90.0% - (9 of 10 people)
  • 1 - 2 years: 75.0% - (9 of 12 people)
  • 2 - 5 years: 50.0% - (7 of 14 people)
  • 5 - 10 years: 85.0% - (6 of 7 people)
  • 10+ years: 90.0% - (10 of 11 people)
  • not specified: 0.0% - (0 of 1 people)
Sertraline:
  • < 1 month: 25.0% - (1 of 4 people)
  • 1 - 6 months: 25.0% - (3 of 12 people)
  • 6 - 12 months: 0.0% - (0 of 9 people)
  • 1 - 2 years: 46.0% - (6 of 13 people)
  • 2 - 5 years: 61.0% - (8 of 13 people)
  • 5 - 10 years: 63.0% - (7 of 11 people)
  • 10+ years: 55.0% - (5 of 9 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Coumadin:
  • female: 70.0% - (28 of 40 people)
  • male: 66.0% - (18 of 27 people)
Sertraline:
  • female: 36.0% - (15 of 41 people)
  • male: 50.0% - (15 of 30 people)

Drug effectiveness by age:

Coumadin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 25.0% - (1 of 4 people)
  • 40-49: 76.0% - (10 of 13 people)
  • 50-59: 66.0% - (14 of 21 people)
  • 60+: 71.0% - (20 of 28 people)
Sertraline:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 40.0% - (2 of 5 people)
  • 40-49: 46.0% - (6 of 13 people)
  • 50-59: 50.0% - (11 of 22 people)
  • 60+: 36.0% - (11 of 30 people)

Most common drug interactions over time *:

< 1 month:
  • international normalised ratio increased
  • atrial fibrillation
  • dehydration
  • dyspnoea
  • sepsis
  • gastrointestinal haemorrhage
  • haematuria
  • international normalised ratio decreased
  • multi-organ failure
  • anaemia
1 - 6 months:
  • international normalised ratio increased
  • hepatic failure
  • thrombocytopenia
  • bradykinesia
  • bradyphrenia
  • confusional state
  • cerebral haemorrhage
  • liver disorder
  • atrial fibrillation
  • blindness transient
6 - 12 months:
  • hyperthyroidism
  • hypothyroidism
  • oedema peripheral
  • international normalised ratio increased
  • renal failure acute
  • petechiae
  • deep vein thrombosis
  • fluid retention
  • haematuria
  • pain
1 - 2 years:
  • anxiety
  • nephrogenic systemic fibrosis
  • gangrene
  • cough
  • pain in extremity
  • pneumonia
  • cellulitis
  • impaired healing
  • mental status changes
  • osteomyelitis
2 - 5 years:
  • asthenia
  • atrial septal defect
  • congenital anomaly
  • hypocoagulable state
  • cardiomegaly
  • depression
  • foetal exposure during pregnancy
  • ventricular septal defect
  • anxiety
  • cardiac failure congestive
5 - 10 years:
  • depression
  • anxiety
  • aggression
  • intentional overdose
  • loss of consciousness
  • pleural haemorrhage
  • suicide attempt
  • aphasia
  • arthralgia
  • insomnia
10+ years:
  • chest pain
  • pneumonia
  • pulmonary haemorrhage
  • cardiac failure congestive
  • international normalised ratio increased
  • numbness and tingling
  • numbness in hands or feet
  • pulmonary alveolar haemorrhage
  • short-term memory loss
  • spasticity
not specified:
  • pain
  • anxiety
  • nausea
  • fall
  • dyspnoea
  • fatigue
  • asthenia
  • depression
  • anaemia
  • international normalised ratio increased

Most common drug interactions by gender *:

female:
  • fall
  • anxiety
  • pain
  • nausea
  • fatigue
  • dyspnoea
  • asthenia
  • anaemia
  • depression
  • oedema peripheral
male:
  • pain
  • anxiety
  • dyspnoea
  • nausea
  • fatigue
  • international normalised ratio increased
  • depression
  • asthenia
  • cardiac failure congestive
  • fall

Most common drug interactions by age *:

0-1:
  • muscular weakness
  • tremor
  • bradycardia
  • cerebrovascular accident
  • death
  • dementia alzheimer's type
  • neoplasm malignant
2-9:
  • international normalised ratio increased
  • cardiovascular disorder
  • electrolyte imbalance
  • intentional overdose
  • mental disorder
  • suicide attempt
  • balance disorder
  • irritability
  • cerebral haemorrhage
  • fall
10-19:
  • drug hypersensitivity
  • ill-defined disorder
  • headache
  • international normalised ratio increased
  • nausea
  • arterial occlusive disease
  • asphyxia
  • cardiac failure
  • cellulitis
  • compression fracture
20-29:
  • atelectasis
  • pain
  • anxiety
  • pulmonary embolism
  • vomiting
  • chest pain
  • diarrhoea
  • fatigue
  • nausea
  • pyrexia
30-39:
  • anxiety
  • fatigue
  • weight decreased
  • pain
  • asthenia
  • muscle spasms
  • injury
  • depression
  • urinary tract infection
  • malaise
40-49:
  • anxiety
  • pain
  • pain in extremity
  • depression
  • dyspnoea
  • fatigue
  • headache
  • arthralgia
  • nausea
  • deep vein thrombosis
50-59:
  • pain
  • nausea
  • anxiety
  • depression
  • fatigue
  • dyspnoea
  • bone disorder
  • headache
  • anaemia
  • oedema peripheral
60+:
  • fall
  • international normalised ratio increased
  • dyspnoea
  • anxiety
  • nausea
  • pain
  • cardiac failure congestive
  • asthenia
  • anaemia
  • atrial fibrillation

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Coumadin and Sertraline?

Can you answer these questions?

More questions for: Coumadin, Sertraline

You may be interested in these reviews

More reviews for: Coumadin, Sertraline

On eHealthMe, Coumadin (warfarin sodium) is often used to treat atrial fibrillation/flutter. Sertraline (sertraline hydrochloride) is often used to treat depression. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.